Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,759.00
Bid: 1,751.00
Ask: 1,753.00
Change: 7.00 (0.40%)
Spread: 2.00 (0.114%)
Open: 1,754.00
High: 1,759.00
Low: 1,733.00
Prev. Close: 1,752.00
IMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IMS and Strategy Review conclusions

7 Nov 2019 07:00

RNS Number : 5558S
IMI PLC
07 November 2019

7 November 2019

Interim Management Statement and Strategy Review conclusions

IMI, the specialist engineering company, issues the following Interim Management Statement, which covers the third quarter from 1 July to 30 September 2019 (unless otherwise indicated, comparatives reflect results on an organic constant currency basis). We also present the conclusions reached following our strategy review.

Current trading and outlook

Good progress is being made with the Group's recently announced business improvement and cost-reduction initiatives.

Trading in the third quarter, for each of the divisions, has continued largely as expected. Where markets have been weak, the businesses have acted decisively to reduce costs and protect margins. Revenues for the third quarter were, on an organic basis, 2% lower compared to 2018 and, before adjusting for the impact of foreign exchange movements, flat on an adjusted basis. Despite lower sales, the Group achieved higher margins in the quarter.

In the second half of 2019 we continue to expect that organic revenue will experience a decline similar to that in the first half, when compared with the same period in 2018. Nonetheless, second half profits are expected to be similar to last year, supported by the business improvement initiatives pursued by each of the three divisions.Based on current market conditions, we expect full year 2019 results to be in-line with current market expectations.

IMI Precision Engineering

On an organic basis, Precision Engineering revenues in the three months to the end of September were 4% lower compared to the same period last year and, before adjusting for the impact of foreign exchange movements, were 2% lower on an adjusted basis.

Sales in Industrial Automation were 7% lower when compared to the third quarter of 2018. Sales in Commercial Vehicle decreased 4% in the quarter with continued good growth in Energy, Life Sciences and Rail.

Given the expectation for continued softness in both the Industrial Automation and Commercial Vehicle segments, organic revenue in the second half is still expected to be down when compared to last year.

IMI Critical Engineering

In the three months to the end of September, order intake was 10% lower due to significant new projects booked in Petrochemical and Water in the same period in 2018. Aftermarket orders were 4% higher than the comparable period in 2018. Year-to-date orders are 8% higher than last year.

The division's order book at the end of September 2019, at 拢563m, was 7% above the same point last year. Margins in the order book are now up compared to those at the same point in 2018, reflecting some improvement in New Construction due to project mix.

In the three months to the end of September, organic revenues were 1% lower when compared to the same period last year, with 16% growth in Aftermarket offsetting a similar decline in New Construction. On an adjusted basis, revenues were 1% higher in comparison to the same period last year.

Although it is only a few weeks since IMI acquired PBM, early progress with its integration has been good and we remain optimistic about the opportunities the combination presents.

In the full year, we continue to expect revenue to be about 7% lower, broadly consistent with the position of the closing order book of 2018. We continue to expect second half margins to be higher as a result of increased Aftermarket sales and the benefits of restructuring.

IMI Hydronic Engineering

Hydronic Engineering organic revenues in the three months to the end of September were 2% higher when compared to the same period last year and 2% higher on an adjusted basis.

Further good progress has been made towards our objective of improved margins, with value pricing and good cost-control contributing to the division's improvement.

In the second half, on an organic basis, we expect our self-help initiatives to deliver improved profits from broadly flat revenues, when compared to the same period in 2018. In the full year we expect our business improvement initiatives to deliver improved sales, profits and margins when compared to 2018.

Strategy Review conclusions

Having presented early findings and actions from our strategy review with the Interim Results in July, we have now completed the full review process, ahead of the original timetable. Most importantly, the review confirms that we have significant value creation opportunities across our businesses as we enter the next phase of IMI's development.

The time for prioritising internal and operational issues has passed. IMI now has a much-improved manufacturing base which we will leverage for all our stakeholders. To take the Group forward, the areas for the greatest change in approach are as follows:

路; We have developed much greater clarity on where and how we win, establishing exactly what differentiators we can leverage and in which specific markets.

路; We are taking significant steps to create a customer-driven culture.

路; We have established new organisational structures and upgraded key roles to improve commercial accountability and to enable IMI to improve through-cycle returns significantly for our shareholders.

路; We have made significant progress pursuing opportunities in pricing, especially in the aftermarket and in our long 'tail' of products. Selling price rises are already running at more than twice the 0.7% average of the last few years.

We have also begun the process of removing significant structural costs from across the Group.

路; As we announced in July, the Group Executive team has been reduced from 11 to 7.

路; IMI Precision is targeting a further 拢35m annualised savings from a new c.拢75m multi-year restructuring to streamline its business and address supply chain complexities in both Europe and the Americas. This programme will place the business on an even stronger competitive footing and is in addition to the 拢35m of group-wide rationalisation already announced for 2019. Some of these plans have been initiated, so we now expect the full-year Group charge in 2019 to be c.拢55m.

路; IMI Critical has placed under review lower-margin businesses accounting for20%-30% of revenue, because their products may not meet the Group's long-term growth and margin aspirations.

路; IMI Hydronic has already made substantial progress in improving its margins and has further plans to streamline its supply chain.

By executing on these key strategic areas, we believe IMI will be a fundamentally stronger business that will deliver significant improvement in returns over the next few years. In particular, the plans of the respective businesses give us confidence about both their ability to grow and their realistic returns:

路; We see that IMI Precision has all of the characteristics of a 20% margin business at the top of the cycle.

路; IMI Critical will be a 17-20% margin business, with an acute focus on the Aftermarket and higher growth sectors.

路; IMI Hydronic will be a 20% margin business.

Regarding Capital Allocation, IMI plans to maintain capital spend at similar levels to the last five years, as the Group continues to see opportunity to improve each business while delivering cash paybacks of less than three years. We plan to continue to pay a progressive dividend whilst improving dividend cover through profit and margin growth. Finally, we will continue to pursue acquisitions that support our strategic plans and will maintain our strict discipline of requiring a return in excess of IMI's cost of capital by year three.

Exchange rates

IMI's financial results are being favourably impacted by the effects of exchange rate movements compared to 2018, and in particular by the weakening of Sterling against the US Dollar. At current rates, this would translate to an exchange rate tailwind for the full year of around 1% on both revenues and profits.

Preliminary results

IMI will issue its preliminary results announcement in respect of the year ending 31 December 2019 on 28 February 2020.

A live webcast for analysts and investors will be held at 09:00 GMT today to discuss this statement. To access the webcast, please go to https://www.imiplc.com/investors. A recording will be on our website from 2pm.

Enquiries to:

John Dean

IMI

Tel: +44 (0)121 717 3712

Suzanne Bartch / Gayden Metcalfe

Teneo

Tel: +44 (0)20 7420 3189

Cautionary Statement:

This Interim Management Statement contains forward-looking statements which are made in good faith based on the information available at the time of its approval. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a number of risks and uncertainties that are inherent in any forward-looking statement which could cause actual results to differ materially from those currently anticipated.

Notes to editors

IMI plc

IMI plc, the specialist engineering company, designs, manufactures and services highly engineered products that control the precise movement of fluids. IMI has manufacturing facilities in more than 20 countries and operates a global service network. The Company is listed on the London Stock Exchange. Further information is available at www.imiplc.com.

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
TSTFSSFAMFUSELF
Date   Source Headline
17th Jul 20209:36 amRNSDirector/PDMR Shareholding - Replacement
15th Jul 20202:32 pmRNSDirector/PDMR Shareholding
2nd Jul 202011:37 amRNSBlock listing Interim Review
1st Jul 202010:30 amRNSTotal Voting Rights
10th Jun 202011:06 amRNSDirector/PDMR Shareholding
1st Jun 20209:11 amRNSTotal Voting Rights
20th May 20201:57 pmRNSHolding(s) in Company
13th May 20202:06 pmRNSDirector/PDMR Shareholding
7th May 20201:04 pmRNSResult of AGM
7th May 20207:00 amRNSInterim Management Statement & Coronavirus update
1st May 202010:03 amRNSTotal Voting Rights
30th Apr 20204:48 pmRNSHolding(s) in Company
27th Apr 20205:27 pmRNSDisclosure of rights attached to equity shares
21st Apr 20201:07 pmRNSChange of Venue for the 2020 AGM
21st Apr 202012:30 pmRNSDirector Declaration
16th Apr 20204:26 pmRNSHolding(s) in Company
15th Apr 20202:20 pmRNSDirector/PDMR Shareholding
14th Apr 20204:42 pmRNSDirector/PDMR Shareholding
1st Apr 20209:56 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSCoronavirus update
26th Mar 20203:58 pmRNSHolding(s) in Company
18th Mar 20204:56 pmRNSDirector/PDMR Shareholding
17th Mar 20204:37 pmRNSDirector/PDMR Shareholding
12th Mar 202010:52 amRNSDirector/PDMR Shareholding
11th Mar 202012:18 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:10 pmRNSTotal Voting Rights
28th Feb 20207:00 amRNSPreliminary results, year ended 31 December 2019
12th Feb 20203:07 pmRNSDirector/PDMR Shareholding
3rd Feb 202010:55 amRNSTotal Voting Rights
15th Jan 202012:15 pmRNSDirector/PDMR Shareholding
13th Jan 20203:31 pmRNSHolding(s) in Company
3rd Jan 202011:54 amRNSBlock listing Interim Review
2nd Jan 20202:04 pmRNSTotal Voting Rights
11th Dec 20192:40 pmRNSDirector/PDMR Shareholding
2nd Dec 201910:20 amRNSTotal Voting Rights
27th Nov 20199:00 amRNSNon-executive director changes
21st Nov 20198:10 amRNSDirector/PDMR Shareholding
14th Nov 201910:04 amRNSDirector/PDMR Shareholding
7th Nov 20197:00 amRNSIMS and Strategy Review conclusions
1st Nov 201910:04 amRNSTotal Voting Rights
9th Oct 20192:07 pmRNSDirector/PDMR Shareholding
1st Oct 201910:17 amRNSTotal Voting Rights
23rd Sep 20197:00 amRNSCompletion of PBM acquisition
16th Sep 20193:51 pmRNSDirector/PDMR Shareholding
11th Sep 20191:08 pmRNSDirector/PDMR Shareholding
2nd Sep 201910:18 amRNSTotal Voting Rights
20th Aug 20197:00 amRNSProposed acquisition of PBM for $85m
14th Aug 20191:42 pmRNSDirector/PDMR Shareholding
12th Aug 20193:40 pmRNSNon-executive director change
1st Aug 20194:17 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.